Needham & Company LLC Reaffirms “Buy” Rating for Trulieve Cannabis (OTCMKTS:TCNNF)

Needham & Company LLC restated their buy rating on shares of Trulieve Cannabis (OTCMKTS:TCNNF) in a research report released on Tuesday, Benzinga reports. Needham & Company LLC currently has a $14.50 price objective on the stock.

Separately, Roth Mkm upped their price target on shares of Trulieve Cannabis from $16.00 to $19.00 and gave the stock a buy rating in a research report on Friday, May 10th.

Trulieve Cannabis Stock Up 12.5 %

OTCMKTS TCNNF opened at $10.28 on Tuesday. The stock’s 50-day moving average is $9.60 and its 200-day moving average is $10.31. Trulieve Cannabis has a one year low of $3.42 and a one year high of $14.50.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands.